Anlon Healthcare Ltd

BSE: 544497

31

total announcements

544497.BO · 15 min delayed

AnnouncementsDiscussion
BSEBoard MeetingResults5d ago

Anlon Healthcare Ltd

Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026 and Auditor''s Limited Review Reports thereon. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 29/10/2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026.

Read more →📎 1 attachment
BSEBoard MeetingFundraise13 Oct 2026

Anlon Healthcare Ltd

Outcome of Board Meeting of ANLON HEALTHCARE LIMITED

Anlon Healthcare Ltd has announced the outcome of its Board Meeting, where it has approved a proposal to raise funds by issuing warrants convertible into equity shares on a preferential basis, up to Rs.250 crores. The details of the issuance, including the number of securities, price, and allotment process, will be decided in the ensuing board meeting. The preferential issue will be undertaken for cash consideration.

Read more →📎 1 attachment
BSEBoard MeetingExpansion29 Sept 2026

Anlon Healthcare Ltd

Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve to discuss and deliberate upon the Company''s business expansion plans in India and/or overseas, and the raising of funds/ financing thereof, in one or more tranches, through such permissible modes and means as the board of directors may deem fit, including by way of equity, debt, hybrid instruments, ....

Anlon Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/10/2026 to discuss business expansion plans in India and/or overseas and the raising of funds/financing thereof.

Read more →📎 1 attachment
BSECompany Update24 Sept 2026

Anlon Healthcare Ltd

We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has informed the exchanges about its participation in the Bharat Connect Conference: Rising Stars 2026 organized by Arihant Capital. The company's management will participate in the virtual conference on September 29, 2026, and no unpublished price-sensitive information will be shared or discussed.

Read more →📎 1 attachment
BSECompany UpdateRegulatory16 Sept 2026

Anlon Healthcare Ltd

The Exchange has sought clarification from Anlon Healthcare Ltd on September 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.

The BSE has sought clarification from Anlon Healthcare Ltd regarding significant price movement, to ensure investors have relevant information and to safeguard their interests.

Read more →
BSECompany UpdateResults14 Aug 2026

Anlon Healthcare Ltd

We have attached herewith Monitoring Agency Report for the quarter ended June 30, 2026. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations. The report, issued by Crisil Ratings Limited, indicates that the company has utilized the IPO proceeds in line with the objects stated in the prospectus, with no deviations observed.

Read more →📎 1 attachment
BSECorp. ActionM&A13 Aug 2026

Anlon Healthcare Ltd

We have attached herewith intimation for fixes Book Closure for Annual General Meeting. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has announced the outcome of its Board meeting, where it has approved several matters, including the audited financial statements for FY 2026, appointment of a new director, regularization of another director, appointment of an internal auditor, and approval of remuneration of the cost auditor. The company has also approved the increase in authorized share capital and the adoption of share swap agreements for the acquisition of up to 44.94% shareholding in Apiqo Organics Private Limited and up to 47.41% shareholding in Bizotic Lifescience Private Limited.

Read more →📎 1 attachment
BSECorp. ActionResults13 Aug 2026

Anlon Healthcare Ltd

We have attached herewith intimation for record fixed for Annual General Meeting. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has announced the fixing of a record date for its Annual General Meeting. The meeting will consider various matters, including the audited financial statements, appointment of a director, regularization of another director, and approval of share swap agreements with two companies. The company will also issue equity shares on a preferential basis to the identified shareholders of the two companies.

Read more →📎 1 attachment
BSECompany UpdateResults12 Aug 2026

Anlon Healthcare Ltd

We have attached herewith earning call transcript. Kindly take the same on your record. Thank you.

Anlon Healthcare Ltd has released the transcript of its Q1 FY27 earnings conference call, which was held on August 6, 2026. The company's EBITDA margin moderated to approximately 17% due to a sharp increase in raw material prices and the consolidation of operating expenses from its recent acquisition, Remember India Health links. Despite this, the company's total income for the quarter stood at 87.62 crore, a significant increase driven by the consolidation of its recent acquisition and organic growth in its core businesses. The company has completed the acquisition of a 63.98% stake in Remember India Health links, which provides access to over 30 formula dossiers.

Read more →📎 1 attachment
Page 1 of 2Next →